$28.58 +0.34 (%) AstraZeneca Shs Sponsored American Deposit Share Repr 1/2 Sh - New York Stock Exchange, Inc.

Jan. 13, 2017 | 04:00 PM

Headlines

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Partner Headlines

  1. Analysts See Merck Rally Continuing After Lung Cancer Drug News

    TalkMarkets | Jan. 12, 2017 | 14:31PM EST
  2. Bristol-Myers Threatens Merck's 'Head Start' In Lung Cancer: Analyst

    Investors Business Daily | Jan. 12, 2017 | 11:14AM EST
  3. Merck Lung-Cancer Drug May Get OK For Large Patient Population

    Investors Business Daily | Jan. 11, 2017 | 12:28PM EST
  4. Bristol-Myers slips after FDA gives Merck lung cancer therapy priority review

    TalkMarkets | Jan. 11, 2017 | 11:50AM EST
  5. Which Top 5 Biotech Stocks In 2016 Are Slated For Triple-Digit Gains?

    Investors Business Daily | Dec. 30, 2016 | 12:45PM EST
  6. Which Top 5 Biotech Stocks In 2016 Are Slated For Triple-Digit Gains?

    Investors Business Daily | Dec. 30, 2016 | 12:45PM EST
  7. Cempra Plunges To 52-Week Low, Shire Drug Label Expanded

    TalkMarkets | Dec. 30, 2016 | 10:33AM EST
  8. Stock Futures Lull, Pfizer Climbs On AstraZeneca Deal

    Investors Business Daily | Dec. 23, 2016 | 08:03AM EST
  9. Tesaro Ovarian Cancer Drug Gets Priority Review After FDA OKs Clovis Med

    Investors Business Daily | Dec. 20, 2016 | 11:28AM EST
  10. Conatus Pharma Skyrockets On Novartis NASH Liver Drug Licensing Deal

    Investors Business Daily | Dec. 19, 2016 | 17:52PM EST
  11. Clovis Jumps After Securing FDA Approval For Ovarian Cancer Drug

    TalkMarkets | Dec. 19, 2016 | 17:18PM EST
  12. Bristol-Myers Will Gain In Lung Cancer Square-Off Vs. Merck: Jefferies

    Investors Business Daily | Dec. 19, 2016 | 14:25PM EST
  13. Clovis Stock Rallies After AstraZeneca-Rivaling Ovarian Cancer Win

    Investors Business Daily | Dec. 19, 2016 | 13:28PM EST
  14. Jefferies Says Sell Merck, Buy Bristol-Myers Heading Into New Year

    TalkMarkets | Dec. 19, 2016 | 12:48PM EST
  15. Missing Phrase May Give Clue To Alexion Shake-Up, Analyst Says

    Investors Business Daily | Dec. 13, 2016 | 15:13PM EST
  16. Large Cap Best & Worst Report - Tuesday, Dec. 13

    TalkMarkets | Dec. 13, 2016 | 08:51AM EST
  17. Alexion Drops After CEO, CFO Resign Amid Soliris Sales Probe

    TalkMarkets | Dec. 12, 2016 | 11:09AM EST
  18. Alexion Tanks After CEO, CFO Unexpectedly Resign Amid Sales Probe

    Investors Business Daily | Dec. 12, 2016 | 10:57AM EST
  19. Week In Review: JHL Biotech Signs $257 Million Biosimilar Deal With Sanofi

    TalkMarkets | Dec. 10, 2016 | 12:44PM EST
  20. Broadcom, Finisar Price Targets Hiked; AstraZeneca A Top Pick

    Investors Business Daily | Dec. 9, 2016 | 08:57AM EST
  21. Better Than The Maestro

    TalkMarkets | Nov. 28, 2016 | 23:53PM EST
  22. Lilly Alzheimer's Drug Fails, J&J in Acquisition Talks With ALIOF

    TalkMarkets | Nov. 28, 2016 | 11:59AM EST
  23. Calithera Pharma In Focus Part 1 - Checkpoint Inhibition

    TalkMarkets | Nov. 16, 2016 | 07:21AM EST
  24. Everything Is Soaring As Trump Makes Buying Stuff Great Again

    TalkMarkets | Nov. 10, 2016 | 07:06AM EST
  25. Pharmaceutical Stocks Surge After Republican Victory

    TalkMarkets | Nov. 9, 2016 | 12:48PM EST
  26. Week In Review: China Resources Pharma To Price $2 Billion Hong Kong IPO This Week

    TalkMarkets | Oct. 15, 2016 | 14:42PM EST
  27. Pharma Stock Roundup: Allergan Acquisitions in Focus, J&J to Buy Abbott's AMO

    TalkMarkets | Sep. 23, 2016 | 12:15PM EST
  28. Don’t Worry, AbbVie Will Be Just Fine

    Dividend.com | Aug. 31, 2016 | 08:00AM EST
  29. Why This Europe ETF Is Beating Rivals By A Mile As U.K. Cuts Rates

    Investors Business Daily | Aug. 4, 2016 | 17:12PM EST
  30. Apple, Facebook, Alphabet, Amazon, Ford, McDonald's Headline Busy Week

    Investors Business Daily | Jul. 29, 2016 | 11:13AM EST
  31. Stock Futures Mixed; Facebook Leaps, Netsuite Soars

    Investors Business Daily | Jul. 28, 2016 | 07:56AM EST
  32. Investing Action Plan: Apple, Facebook, Amazon, Big Oil, Boeing, Fed

    Investors Business Daily | Jul. 23, 2016 | 07:00AM EST
  33. Relypsa Getting Acquired By Swiss Partner Seeking U.S. Entry

    Investors Business Daily | Jul. 21, 2016 | 11:25AM EST
  34. Incyte Plummets After Stopping Trial Of Jakafi In Pancreatic Cancer

    IBD | Feb. 11, 2016 | 11:16AM EST
  35. Stocks Down More Than 3%; Facebook Triggers Sell Signal

    IBD | Feb. 8, 2016 | 15:10PM EST
  36. Benzinga's Top Downgrades

    Benzinga | Feb. 8, 2016 | 09:38AM EST
  37. Fitbit PT Cut; Apple Supplier Skyworks Upgraded

    IBD | Jan. 19, 2016 | 12:55PM EST
  38. Fitbit PT Cut; Apple Supplier Skyworks Upgraded

    IBD | Jan. 19, 2016 | 09:36AM EST
  39. Benzinga's Top Upgrades

    Benzinga | Jan. 19, 2016 | 09:16AM EST
  40. Juno Buyout Puts Single-Cell Sequencing In Spotlight

    IBD | Jan. 15, 2016 | 17:30PM EST
  41. Dynavax Hepatitis B Vaccine Beats Glaxo's In Trial

    IBD | Jan. 7, 2016 | 15:40PM EST
  42. Dynavax Hepatitis B Vaccine Beats Glaxo's In Trial

    IBD | Jan. 7, 2016 | 14:51PM EST
  43. 3 Potential Blockbuster Drugs Launching in 2016

    IBD | Jan. 6, 2016 | 09:42AM EST
  44. Must Watch Stocks for Today

    Benzinga | Dec. 28, 2015 | 03:42AM EST
  45. Benzinga's Volume Movers

    Benzinga | Dec. 24, 2015 | 10:33AM EST
  46. Benzinga's Top #PreMarket Gainers

    Benzinga | Dec. 24, 2015 | 08:19AM EST
  47. Jim Cramer Gives His Opinion On AstraZeneca, Cummins And Dow Chemical

    Benzinga | Dec. 20, 2015 | 18:55PM EST
  48. Benzinga's M&A Chatter for Thursday December 17, 2015

    Benzinga | Dec. 17, 2015 | 18:41PM EST
  49. AstraZeneca On Buyout Trail

    IBD | Dec. 17, 2015 | 18:30PM EST
  50. AstraZeneca toAcquire 55% Stake in Acerta for Upfront Payment of $2.5B

    Benzinga | Dec. 17, 2015 | 05:30AM EST
Trading Center